RxDoctor Payments Data

John Wixted, MD

Orthopaedic Surgery · Boston, MANPI 1306827134

Payments from drug & device makers

$17,318in general payments, 2019–2025

Across 62 payments — averaging $279.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes GmbH$13K
  • Stryker$2K
  • Orthoxel Designated Activity Company$1K
  • Osteocentric Technologies, Inc.$586
  • Zimmer Biomet$375
  • Johnson & Johnson$291
  • plus $373 from 5 others

What the payments were for

  • Consulting fees$5003%
  • Speaking & faculty fees$7,65044%
  • Travel & lodging$6,04535%
  • Food & beverage$3,12318%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Synthes GmbH13$13,018
Stryker23$1,675
Orthoxel Designated Activity Company2$1,000
Osteocentric Technologies, Inc.8$586
Zimmer Biomet4$375
Johnson & Johnson5$291
SIGN Fracture Care International1$150
Kerecis Limited1$84
Smith+Nephew3$77
Lifenet Health1$47
Orthofix Medical, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,318 in reported general payments places this provider in the 75th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$174,000
Medicare patients
283
Services billed
503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →